WHO WE ARE
Allterum Therapeutics, Inc., is a biopharmaceutical company developing a monoclonal antibody therapy for pediatric patients with relapsed acute lymphoblastic leukemia. Allterum was founded in 2018 by Fannin Innovation Studio in Houston, TX.
Why Allterum Therapeutics
Partner post not found!
Our Partnerships & Collaborators
``I am excited to work with Allterum to develop a much-needed option for the treatment of children with T-cell ALL.``
Eric Schafer, M.D., M.H.S.Assist. Professor, Pediatrics-Oncology | Texas Children's Hospital & Baylor College of Medicine
”After years of searching for a way to help those kids who have no effective treatment for their leukemia, I’m thrilled to see Allterum take our antibody into the clinic.”
Scott Durum, Ph.D.Inventor | Cytokine and Immunity Section | National Cancer Institute
STAY UP TO DATE
Advancing an innovative solution for a critical and unmet medical need